Q/C Technologies Inc (QCLS) Stock Price, Quote & News

Company Profile

Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog o...

Industry: Computer Hardware

Sector: Technology

Phone: 856 848 8698

Website: tnfpharma.com

Address:

1185 Avenue of the Americas, Suite 249, New York, United States

fdhbdfbcvbfg Dec. 5 at 10:23 AM

$PLTR $QCLS https://www.linkedin.com/posts/vonnie-soto-420b02398_%F0%9D%99%85%F0%9D%99%A4%F0%9D%99%9E%F0%9D%99%A3-%F0%9D%99%A4%F0%9D%99%AA%F0%9D%99%A7-%F0%9D%99%92%F0%9D%99%9D%F0%9D%99%96%F0%9D%99%A9-%F0%9D%99%A8%F0%9D%98%BC%F0%9D%99%A5%F0%9D%99%A5-%F0%9D%99%9C%F0%9D%99%A7%F0%9D%99%A4%F0%9D%99%AA%F0%9D%99%A5-activity-7402643534031515648-thzv?utm_source=share&utm_medium=member_desktop&rcm=ACoAAGGyE9gByAkRl6qcTDmfsWyWFNdYMoFgJP4

0 · Reply

MegaFat Dec. 5 at 10:19 AM

$QCLS About Q/C Technologies, Inc. Q/C Technologies is pioneering the next generation of energy-efficient quantum class, high-performance computing infrastructure. Through a licensing agreement with LightSolver, Q/C holds exclusive rights to the use of innovative quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. Q/C bridges a disruptive computing paradigm for high-speed photonic computing at scale, unlocking unprecedented performance and sustainability for next generation applications and post quantum security. ir.qctechnologies.com

0 · Reply

Sarandon Dec. 5 at 10:18 AM

$BLIN ultra low float add it to watchlist. How I wake up could be impressive 💪 $SMX $QCLS $CRML $SOFI

0 · Reply

Core786 Dec. 5 at 10:03 AM

$QCLS i’m making myself comfortable and sitting firmly on this one

0 · Reply

MegaFat Dec. 5 at 10:03 AM

$QCLS you understand there's a business shift? Q/C Technologies Inc. (QCLS) shares soared over 60% on Thursday, extending Wednesday’s gains as American pharma investor Martin Shkreli announced that he had purchased the company’s shares. “We bought a photonic/optical computing stock: $QCLS. I'm convinced that the answer to frontier computing is optical, not quantum. we're calling it "quantum class" so investors understand it,” Shkreli said in a post on X. He also added that he would join the company as CEO if President Trump allowed it.

0 · Reply

MegaFat Dec. 5 at 10:02 AM

$QCLS give it a few days

0 · Reply

_SonicsPrice Dec. 5 at 9:56 AM

Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $IRBT $PLRZ $OPEN $QCLS Soon

0 · Reply

Mastertrader80 Dec. 5 at 9:55 AM

$DEVS $SNSE $QCLS I was sure this morning these 3 were going to make a nice run ! Watching closely today

0 · Reply

come_litaliano Dec. 5 at 9:35 AM

$QCLS I am completely shocked. I was sure the stock would open this morning at a minimum price of $95. The genius Mr. Martin Shkreli promised the stock price would be $100 🤣🤣🤣🤣🤣🤣🤣 Dear people, get ready for a price of $6 later today.

2 · Reply

GrbiStock Dec. 5 at 9:07 AM

$QCLS 8.27 touched,platforms are down,good momentum incoming

0 · Reply

Martin Shkreli touts QCLS stock as a long idea after a “bad call” on CAPR

Oct 30, 2025, 9:15 AM EDT - 5 weeks ago

Q/C Technologies Introduces Proprietary qc-LPU100™ Brand of Quantum-Class Laser Processing Units

Oct 16, 2025, 9:15 AM EDT - 7 weeks ago

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Sep 25, 2025, 9:15 AM EDT - 2 months ago

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Sep 24, 2025, 9:15 AM EDT - 2 months ago

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Sep 17, 2025, 9:24 AM EDT - 2 months ago

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 8, 2025, 9:15 AM EDT - 3 months ago

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 9:15 AM EDT - 3 months ago

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

Sep 2, 2025, 9:20 AM EDT - 3 months ago

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

PMCB

Sep 2, 2025, 9:15 AM EDT - 3 months ago

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

Aug 28, 2025, 9:15 AM EDT - 3 months ago

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

Aug 19, 2025, 5:20 PM EDT - 3 months ago

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Jun 24, 2025, 9:15 AM EDT - 5 months ago

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

May 8, 2025, 9:20 AM EDT - 7 months ago

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

Apr 22, 2025, 9:15 AM EDT - 8 months ago

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Apr 16, 2025, 9:15 AM EDT - 8 months ago

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

Mar 17, 2025, 9:15 AM EDT - 9 months ago

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

Mar 5, 2025, 9:00 AM EST - 9 months ago

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

Feb 25, 2025, 9:20 AM EST - 10 months ago

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

Jan 29, 2025, 9:15 AM EST - 11 months ago

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

Jan 15, 2025, 9:15 AM EST - 11 months ago

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

Dec 19, 2024, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Dec 9, 2024, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Oct 2, 2024, 9:10 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

Aug 21, 2024, 9:00 AM EDT - 1 year ago

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

fdhbdfbcvbfg Dec. 5 at 10:23 AM

0 · Reply

MegaFat Dec. 5 at 10:19 AM

0 · Reply

Sarandon Dec. 5 at 10:18 AM

$BLIN ultra low float add it to watchlist. How I wake up could be impressive 💪 $SMX $QCLS $CRML $SOFI

0 · Reply

Core786 Dec. 5 at 10:03 AM

$QCLS i’m making myself comfortable and sitting firmly on this one

0 · Reply

MegaFat Dec. 5 at 10:03 AM

0 · Reply

MegaFat Dec. 5 at 10:02 AM

$QCLS give it a few days

0 · Reply

_SonicsPrice Dec. 5 at 9:56 AM

Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $IRBT $PLRZ $OPEN $QCLS Soon

0 · Reply

Mastertrader80 Dec. 5 at 9:55 AM

$DEVS $SNSE $QCLS I was sure this morning these 3 were going to make a nice run ! Watching closely today

0 · Reply

come_litaliano Dec. 5 at 9:35 AM

2 · Reply

GrbiStock Dec. 5 at 9:07 AM

$QCLS 8.27 touched,platforms are down,good momentum incoming

0 · Reply

Core786 Dec. 5 at 9:06 AM

$QCLS platforms are down?

0 · Reply

JohnathnDoe Dec. 5 at 9:02 AM

$QCLS ok so go rent some shares and put up or shut up broke back boy

0 · Reply

welltrade77 Dec. 5 at 8:58 AM

$QCLS $QCLS TNF Pharma name change to Q/C Technologies (QCLS). 1‑for‑100 reverse split in Sep. ZERO revenue no sales. P&amp;D .Good luck 😀

1 · Reply

Toptradersam Dec. 5 at 8:51 AM

$QCLS Shared my full outlook in the video. Let’s GO! 🚀🔥 https://www.youtube.com/watch?v=KWBJzG3Joj0

0 · Reply

erikkkkkkjj Dec. 5 at 8:50 AM

$QCLS

0 · Reply

frankyboyz Dec. 5 at 8:22 AM

Support and retweet: #frankysWL The one and only Franky’s Watchlist Dec. 5, 2025 Edition Your daily dose of high-potential setups & sharp trade ideas to stay ahead. Afterhours Movers – Let’s Dive In: ━━━━━━━━━━━━━━━━━━━━━ $AKAN $QCLS $SPRC $VCIG and few more... https://x.com/frankyboyz/status/1996857552642937269 Franky

0 · Reply

DayTrade_4Life Dec. 5 at 8:06 AM

Watchlist for 5 Dec. Trade at own risk. Opinions, not financial advice. Target 10% to 20% to help ensure profits. LGHL: Support Range 5.75 to 6.68; Breakout 8.15 AKAN: Support Range 1.15 to 1.22; Breakout 1.40 SNSE: Support Range $12 to 14.70; Breakout $19/$20 SUGP: Support Range 7.50 to $9; Breakout 10.20 SPRC: Support Range 1.92 to 2.05; Breakout 2.26 $INHD: Support Range .145 to .16; Breakout .18 $DEVS: Support Range 1.95 to 2.25; Breakout 2.70 $SMX: Support Range $112 to $145; Breakout $190 / $200 $QCLS: Support Range 5.90 to 6.80; Breakout 8.30

0 · Reply

Bluesclues692 Dec. 5 at 8:04 AM

$QCLS dude... Well im not in the play... pump it i guess

1 · Reply

Briantheinvestor Dec. 5 at 7:55 AM

$QCLS Martin’s management and a more salient technology when comping to these BS quantum companies with 1b+ mrkcp = the perfect speculative play. I can make a lot of sense of the EV

0 · Reply

Bluesclues692 Dec. 5 at 7:53 AM

$QCLS yeah what ive been saying

1 · Reply

Briantheinvestor Dec. 5 at 7:53 AM

$QCLS probably the best speculative play on the market. Lets go martin!

0 · Reply

Camelinvesting Dec. 5 at 7:22 AM

$QCLS let’s see if algos want this alive today ! 🔥

0 · Reply

Market Cap	14.08M
Revenue (ttm)	0.00
Net Income (ttm)	-23.36M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	95,751,906
Avg Vol	3,932,434
Day's Range	N/A - N/A
Shares Out	4.17M
Stochastic %K	79%
Beta	2.06
Analysts	Strong Buy
Price Target	N/A